homocysteine has been researched along with Intermittent Claudication in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodmann, M; Gary, T; Hackl, G; Hafner, F; Jud, P; Meinitzer, A; Seinost, G; Verheyen, N | 1 |
| Araki, Y; Fujita, K; Hojo, Y; Ichikawa, S; Iwasaki, T; Kanai, H; Kasama, S; Kumakura, H; Minami, K; Nakashima, K; Sumino, H; Takayama, Y | 1 |
| Criqui, MH; Ferrucci, L; Green, D; Guralnik, JM; Liao, Y; Liu, K; McCue, K; McDermott, MM; Pearce, WH; Ridker, P; Rifai, N; Schneider, JR; Tan, J; Tian, L | 1 |
| Armon, MP; Clark, A; Finglas, PM; Jennings, B; Khandanpour, N; Meyer, FJ; Willis, G | 1 |
| Conti, E; Favaretto, E; Frascaro, M; Legnani, C; Palareti, G; Sartori, M | 1 |
| Völler, H | 1 |
| Homer-Vaniasinkam, S; Naseem, KM; Nicolaou, A; Riba, R; Troxler, M | 1 |
| Superko, HR | 1 |
| Assmann, G; Breithardt, G; Cullen, P; Erren, M; Fobker, M; Junker, R; Kerber, S; Kropf, J; Reinecke, H; Schulte, H; Schurek, JO | 1 |
| Hiatt, WR; Regensteiner, JG | 1 |
| Holm, AC; Lassvik, C; Malinow, MR; Mölgaard, J; Olsson, AG; Upson, B | 1 |
1 review(s) available for homocysteine and Intermittent Claudication
| Article | Year |
|---|---|
Current medical therapies for patients with peripheral arterial disease: a critical review.
Topics: Angiotensin-Converting Enzyme Inhibitors; Arteriosclerosis; Cardiovascular Diseases; Cilostazol; Diabetes Mellitus; Estrogens; Exercise; Homocysteine; Humans; Hyperlipidemias; Hypertension; Intermittent Claudication; Meta-Analysis as Topic; Myocardial Ischemia; Pentoxifylline; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Smoking; Tetrazoles | 2002 |
1 trial(s) available for homocysteine and Intermittent Claudication
| Article | Year |
|---|---|
Randomized clinical trial of folate supplementation in patients with peripheral arterial disease.
Topics: Aged; Aged, 80 and over; Ankle Brachial Index; Blood Flow Velocity; Cardiovascular Agents; Dietary Supplements; Double-Blind Method; Female; Folic Acid; Homocysteine; Humans; Intermittent Claudication; Male; Middle Aged; Tetrahydrofolates; Treatment Outcome | 2009 |
9 other study(ies) available for homocysteine and Intermittent Claudication
| Article | Year |
|---|---|
Age-dependent effects of homocysteine and dimethylarginines on cardiovascular mortality in claudicant patients with lower extremity arterial disease.
Topics: Aged; Aging; Arginine; Austria; Cardiovascular Diseases; Female; Homocysteine; Humans; Incidence; Intermittent Claudication; Lower Extremity; Male; Prospective Studies; Risk Factors; Survival Rate | 2018 |
Differences in brain natriuretic peptide and other factors between Japanese peripheral arterial disease patients with critical limb ischemia and intermittent claudication.
Topics: Adult; Aged; Aged, 80 and over; Albumins; Angiography; Ankle Brachial Index; Asian People; Body Mass Index; Cholesterol; Female; Fibrinogen; Glomerular Filtration Rate; Homocysteine; Humans; Intermittent Claudication; Ischemia; Japan; Leg; Male; Middle Aged; Natriuretic Peptide, Brain; Peripheral Arterial Disease; Prevalence; Risk Factors; Sex Factors; Smoking | 2013 |
Circulating blood markers and functional impairment in peripheral arterial disease.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Blood Pressure; Disability Evaluation; Exercise Test; Female; Fibrin Fibrinogen Degradation Products; Follow-Up Studies; Geriatric Assessment; Homocysteine; Humans; Inflammation Mediators; Intermittent Claudication; Male; Middle Aged | 2008 |
Thrombotic risk factors and cardiovascular events after endovascular intervention for peripheral arterial disease.
Topics: Aged; Angioplasty; Cardiovascular Diseases; Factor V; Factor VIII; Female; Fibrinogen; Homocysteine; Humans; Intermittent Claudication; Ischemia; Leg; Lupus Coagulation Inhibitor; Male; Peripheral Arterial Disease; Proportional Hazards Models; Risk Factors; Stents; Thrombophilia; Thrombosis | 2011 |
Peripheral arterial disease (PAD): secondary prevention.
Topics: Adult; Age Factors; Aged; Arteriosclerosis; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Diagnosis, Differential; Female; Homocysteine; Humans; Hypertension; Hypolipidemic Agents; Intermittent Claudication; Life Style; Lipids; Male; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Prevalence; Prognosis; Risk Factors; Sensitivity and Specificity; Sex Factors; Smoking | 2002 |
Altered platelet reactivity in peripheral vascular disease complicated with elevated plasma homocysteine levels.
Topics: Adenosine Diphosphate; Aged; Blood Platelets; Fibrinogen; Flow Cytometry; Homocysteine; Humans; Intermittent Claudication; Middle Aged; Nitric Oxide; Nitric Oxide Donors; P-Selectin; Peripheral Vascular Diseases; Platelet Activation; S-Nitrosoglutathione; Sulfhydryl Compounds | 2004 |
Elevated high-density lipoprotein cholesterol, not protective in the presence of homocysteinemia.
Topics: Aged; Aged, 80 and over; Angina Pectoris; Cholesterol, HDL; Coronary Disease; Female; Homocysteine; Humans; Intermittent Claudication; Risk Factors | 1997 |
Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries.
Topics: Acute-Phase Reaction; Adult; Aged; Arteritis; Biomarkers; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Constriction, Pathologic; Coronary Artery Disease; Female; Fibrinogen; Homocysteine; Humans; Interleukin-6; Intermittent Claudication; Logistic Models; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Popliteal Artery; Risk Assessment; Transforming Growth Factor beta; Triglycerides | 1999 |
Hyperhomocyst(e)inaemia: an independent risk factor for intermittent claudication.
Topics: Aged; Exercise Test; Folic Acid; Homocysteine; Homocystine; Humans; Intermittent Claudication; Lipids; Logistic Models; Male; Middle Aged; Risk Factors | 1992 |